Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.72%
Insider Ownership
16.39%
Institutional Own.
63.11%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GC012F Details Multiple myeloma, Cancer | Phase 1/2 Data readout | |
GC012F Details Autoimmune disease, Systemic lupus erythematosus | Phase 1/2 Initiation | |
GC007g Details B-cell acute lymphoblastic leukemia | Failed Discontinued |